SENTARA ALBEMARLE REGL MED CTR LLC — History
CCN 340109 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$140M
Latest Revenue (FY2022)
+9.8%
Revenue CAGR (3yr)
-1.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $116M | $144M | $140M | -2.3% | +9.8% |
| Operating Expenses | $137M | $131M | $142M | +8.7% | +1.7% |
| Operating Margin | -18.1% | 8.9% | -1.3% | -114.4% | +0.0% |
| Net Income | $-21M | $13M | $-2M | -114.0% | +0.0% |
| Licensed Beds | 98 | 98 | 98 | +0.0% | +0.0% |
| Total Patient Days | 17,154 | 20,344 | 20,732 | +1.9% | +9.9% |
| Medicare Day % | 46% | 40% | 37% | -8.3% | -9.9% |
| Medicaid Day % | 10% | 8% | 6% | -28.4% | -23.6% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +20.6% ($116M → $140M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.8%
This Hospital
+7.6%
State Avg
Latest Margin
-1.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $152M | 7.1% |
| FY2024 (proj) | $164M | 15.5% |
| FY2025 (proj) | $176M | 24.0% |